Clinical and Experimental Pharmacology and Physiology · 2004 · 19 citations · 30 references
MedicinePathologyPharmacologyCellular MetabolismGene Expression AnalysisVascular SurgeryCytochrome P450 EnzymesCytochrome P450-mediated MetabolismVenous DiseaseCytochrome P450 BiomarkersCytochrome P450 Enzyme ActivityCytochrome P450 Expression RegulationCytochrome P450 IsoenzymesCytochrome P450 Metabolic PathwaysCytochrome P450 PathwaysVascular Bypass GraftingVenous Bypass Grafting
The expression of cytochrome P450 (CYP) enzymes and cyclo-oxygenases (COX) was investigated in human saphenous veins by reverse transcription-polymerase chain reaction analysis. Non-varicose veins were obtained from patients undergoing aortocoronary bypass grafting, whereas varicose veins were obtained from patients undergoing stripping removal of varicose saphenous veins. In non-varicose veins, CYP1B1, CYP2C, CYP2E1 and CYP4A11 were detected, whereas CYP2J2, CYP3A5, COX-1 and COX-2 were detected almost exclusively in varicose veins. CYP4F2 was not detectable. Except for CYP4A11, the levels of individual CYP mRNA were higher in varicose veins than in control veins. Smooth muscle cell volume, determined by a colour image-analysis system, was increased approximately 1.5-fold in varicose veins. Because CYPs and COXs produce various vasoactive compounds, increased expression of these enzymes could be involved in the impairment of vascular tone and may contribute to varicose pathology. Then, CYP or COX modulators may be potentially active in the treatment of chronic venous insufficiency.
30
Cytochrome P450 2C is an EDHF synthase in coronary arteries
Beate Fißlthaler, Rüdiger Popp, Ladislau Kiss et al. · Nature · 1999 · 910 citations
Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis
Richard A. F. Dixon, Ronald E. Diehl, Evan E. Opas et al. · Nature · 1990 · 776 citations
Ingrid Fleming, Uwe Michaelis, Daniel Bredenkötter et al. · Circulation Research · 2001 · 438 citations · Full text
Medicine, Cardiology, Pharmacology +14